91
|
|
|
Potassium two pore domain channel subfamily K member 4 |
FHEIG, K2p4.1, TRAAK, TRAAK1 |
|
92
|
|
|
Potassium two pore domain channel subfamily K member 5 |
K2p5.1, KCNK5b, TASK-2, TASK2 |
Eczema, Cardiovascular disease, Coronary artery disease, Eating disorder, Gout, Hypertension, Major depressive disorder, Migraine, Myocardial infarction, Nephrolithiasis, Obesity, Open angle glaucoma, Pancreatic cancer, Status epilepticus, Diabetes mellitus type 2, Urolithiasis, Vascular dementiaView all (2 more) |
93
|
|
|
Potassium two pore domain channel subfamily K member 6 |
K2p6.1, KCNK8, TOSS, TWIK-2, TWIK2 |
|
94
|
|
|
Potassium two pore domain channel subfamily K member 7 |
K2p7.1, TWIK3 |
|
95
|
|
|
Potassium two pore domain channel subfamily K member 9 |
BIBARS, K2p9.1, KT3.2, TASK-3, TASK3, TASK32 |
Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Birk-barel syndrome, Color vision deficiency, Colorectal cancer, Dementia, Developmental disability, Absence epilepsy, Major depressive disorder, Mood disorder, Obesity, Psychiatric disorders, Schizophrenia, Scoliosis, Uterine fibroidView all (2 more) |
96
|
|
|
Potassium calcium-activated channel subfamily M alpha 1 |
BKTM, CADEDS, IEG16, KCa1.1, LIWAS, MaxiK, PNKD3, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, hSlo, mSLO1 |
Alzheimer disease, Androgenetic alopecia, Angioedema, Autism, Bell's palsy, Bone disease, Renal cell carcinoma, Cerebellar atrophy with seizures and variable developmental delay, Color vision deficiency, Generalized epilepsy, Idiopathic generalized epilepsy, Eye disease, Gingival diseases, Global developmental delay, Growth disorder, Pulmonary hypertension, Hypospadias, Intellectual developmental disorder, Lung cancer, Metabolic bone disorder, Metabolic syndrome, Obesity, Nonalcoholic fatty liver disease, Non-melanoma skin carcinoma, Osteoarthritis, Osteonecrosis, Paroxysmal nonkinesigenic dyskinesia, Willis-ekbom disease, Schizophrenia, Spastic ataxia, Status epilepticus, Diabetes mellitus type 2View all (17 more) |
97
|
|
|
Potassium calcium-activated channel subfamily M regulatory beta subunit 1 |
BKbeta1, K(VCA)beta, SLO-BETA, hbeta1, hslo-beta, k(VCA)beta-1, slo-beta-1 |
|
98
|
|
|
Potassium calcium-activated channel subfamily M regulatory beta subunit 2 |
- |
Asthma, Bipolar disorder, Lymphoblastic leukemia, Congenital left-sided heart lesions, Connective tissue disease, Cutaneous lupus erythematosus, Dementia, Diabetic neuropathy, Insomnia, Major depressive disorder, Mixed connective tissue disease, Obesity, Schizophrenia, Scoliosis, Amyotrophic lateral sclerosis, Diabetic nephropathyView all (1 more) |
99
|
|
|
Potassium calcium-activated channel subfamily M regulatory beta subunit 3 |
BKBETA3, HBETA3, K(VCA)BETA-3, KCNMB2, KCNMBL, SLO-BETA-3, SLOBETA3 |
|
100
|
|
|
Potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
- |
|
